CWBR News and Press, CohBar Inc. From 10/05/20

MENLO PARK, Calif., Oct. 05, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, announced today that its Chief Executive Officer, Steven Engle, will pr...

MENLO PARK, Calif., Sept. 29, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, announced today that its Chief Executive Officer, Steven Engle, will p...

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Stitcher and Spotify . Economic reports in the week ahead Tesla (NASDAQ:TSLA) will take top billing this week with its highly-anticipated Battery Day event ...

MENLO PARK, Calif., Sept. 10, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, announced today that its Chief Executive Officer, Steven Engle, will p...

MENLO PARK, Calif., Sept. 03, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, announced today that its Chief Executive Officer, Steven Engle, will p...

Penny Stocks, News, & Big Moves When you’re looking for penny stocks to buy , one of the top things to look for is a catalyst. These can come in the form of rumors, filings, and more-popularly, news. For the last 8 months, we’ve watched as countless companies have reported ...

CohBar (NASDAQ: CWBR), a clinical-stage biotechnology company developing mitochondria-based therapeutics to treat chronic diseases, has closed an underwritten public offering of 12,300,000 units, each at a public offering price of $1.22. According to the update, CohBar secured $15 million in g...

MENLO PARK, Calif., Aug. 28, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR) (the “Company”), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, today announced the closing of its previo...

Gainers:  Fluidigm Corporation (NASDAQ: FLDM ) +33% . More news on: Fluidigm Corporation, SCWorx Corp., Anaplan, Inc., Stocks on the move, Read more ...

CohBar (NASDAQ: CWBR ) plunged in trade post it priced earlier announced underwritten public offering of 12.3M units at $1.22/unit; each unit consists of one share and one warrant to purchase 0.75 of a share at a per share exercise price of $1.44. More news on: CohBar, Inc., Healthca...